Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

SAC Health Acquires Former Wells Fargo Building in San Bernardino to Expand Services in the Region.


SAC Health, SAC Health Brier Campus, New Clinic, San Bernardino, SAC Healthcare

Future Site of SAC Health – Brier Campus

“Acquiring the new building will provide us the much-needed space to not only expand our ability to see more patients, but also offer a full range of health care services in one location to streamline the patient experience.” Jason Lohr, MD, CEO of SAC Health

SAC Health, a community-based health center, completed the purchase of the former Wells Fargo regional headquarters building located at 1003 East Brier in San Bernardino, California. The newly acquired building will become part of the network of SAC Health campuses and clinics and will be its 12th location.

Renovations are set to start in the coming months to ensure that the space is appropriately converted for medical use, while extensive planning continues to determine the services that will be offered at the future SAC Health – Brier Campus. Opening of the new location is tentatively planned for the year 2025 and will provide additional space and access-point to health care services in the region.

SAC Health provides care to underserved populations, including Medi-Cal and Medicare, in the following areas: family medicine, pediatrics, behavioral health, dentistry and other specialties. The final list of services provided at the Brier Campus will be announced in the coming months.

This is the third consecutive year that SAC Health has announced plans to open a new clinic in the region. The need for quality healthcare has steadily increased as the region’s population continues to grow. “Acquiring the new building and what will be the latest health campus for SAC Health will provide us the much-needed space to not only expand our ability to see more patients, but also offer a full range of health care services in one location to streamline the patient experience,” explains Jason Lohr, MD, CEO of SAC Health. “Converting the space will also provide us the opportunity to outfit this location to be a modern facility with the latest equipment and technology.”

The future SAC Health – Brier Campus, originally built in 2007, sits on a 14.5-acre site with a five-story building that totals over 280,000 square feet. The campus will have two parking structures that will accommodate easy access for both patients and staff. “It was fortuitous we became aware that the property was available for acquisition at the time SAC Health was looking to expand. The location offers excellent access for patients in the region,” says Lon Mapes, president of LDM Commercial, who represented SAC Health in the acquisition of the property. Sean Fulp, vice chairman with Colliers, represented the seller in the transaction.

More information about SAC Health’s complete list of locations and service area can be found at

http://www.sachealth.org.

About SAC Health

SAC Health is the largest specialty-based and teaching health center (THC) Federally Qualified Health Center (FQHC) in the nation. SAC Health provides comprehensive services to underserved areas and populations including Medi-Cal and Medicare patients. SAC Health is recognized as a Level-3 Patient-Centered Medical Home by the National Committee for Quality Assurance (NCQA) and has over 100 community partnerships that enable the health to provide whole-person care to all its patients. SAC Health provides care in 11 locations, along with a mobile clinic, in San Bernardino and Riverside counties, including services in family medicine; pediatrics and pediatric specialties; obstetrics and gynecology, internal medicine and medical specialties; family dentistry; behavioral health; surgical specialties and more. More information on how to become a patient at SAC Health is available online at sachealth.org.

Share article on social media or email:

Memorial Outpatient Behavioral Health Center to Expand Space and Services


Dr. Tammy Tucker with Dr. Andrew Migliaccio and Dr. Claudia Vicencio at the Grand Opening of Memorial Outpatient Behavioral Health Center

“This expansion is happening just at the right time to respond to our community’s needs and provide a safe space where our mental health experts can empower more patients and provide them the tools they need to achieve wellness,” said Dr. Tammy Tucker, PsyD, VP, Memorial Behavioral Health.

At a time of increased need for mental health services, Memorial Outpatient Behavioral Health Center is expanding its space by 40% with a $5 million initial investment by Memorial Healthcare System. The relocation and expansion of over 7,000 sq-ft will offer an additional 10,080 adult mental health and addiction visits—including psychiatry, behavioral health counseling and primary care services. This expansion will also include additional innovative services, all focused on helping patients achieve health and wellness in all areas of their lives.

Over the next year, the Behavioral Health Center, now located at 5595 South University Drive, Davie, FL, will recruit three additional mental health providers, increase psychiatry resident rotations, and pursue additional federal, state and county grant funding. The plan also includes the creation of a teen and young adult program in partnership with Joe DiMaggio Children’s Hospital.

Mental illnesses are among the most common health conditions in the United States. More than 50% of people will be diagnosed with a mental illness or disorder at some point in their lifetime, and 1 in 5 Americans will experience a mental illness in any given year, according to the Centers for Disease Control and Prevention (CDC).

“On the heels of the pandemic, we have seen an increase in patients experiencing mental health crises in our community, evident also by an influx of patients into our emergency rooms seeking help,” said Tammy Tucker, PsyD, VP, Memorial Behavioral Health. “The expansion of Memorial’s outpatient behavioral health services is happening just at the right time to respond to the needs of our community and provide a safe space where our mental health professionals can empower even more patients and their families and provide them the tools they need to achieve wellness.”

Memorial’s expansion of outpatient services is taking place at a time when other market challenges are exacerbating access issues, barriers to care and health disparities. Inpatient psychiatric programs are closing in Broward County, and payment for private mental health services are shifting from insurance coverage to out-of-pocket expenses.

“We believe our new Behavioral Health Center will be a beacon of hope for those who need mental health and substance abuse services and will have a tremendous impact on the well-being of our patients, caregivers, families and more,” said Claudia Vicencio, PhD, LCSW, LMFT, Director, Outpatient Behavioral Health. “We are proud to offer this expanded space and services and we want people to know that we are here to help.”

As one of the largest public healthcare systems in the nation, Memorial Healthcare System offers comprehensive inpatient and outpatient adult behavioral health and substance abuse services. The multicultural team includes psychiatrists, psychiatric nurse practitioners, social workers, psychologists, psychotherapists, counselors, and peer support specialists who use their lived experiences and skills learned in training to help others achieve and maintain recovery and wellness. In addition to offering traditional mental health services, Memorial offers unique and renowned adult services and treatments including:

Mothers in Recovery

An award-winning, inpatient and outpatient program for pregnant women who are addicted to drugs and/or alcohol to help achieve mother and baby health outcomes.

Rebel’s Drop-In Center

A safe space for adults with behavioral health conditions seeking support and connection. Rebel’s provides free services 365 days a year, including self-help support groups, arts and craft activities, wellness and recreational activities, peer mentoring, and recovery coaching.

Trauma Program

For adults who have experienced traumatic events, including: physical and sexual abuse, and other threats to one’s life and/or physical, emotional or spiritual integrity.

Medication-Assisted Treatment

Evidence-based program for adults struggling with addiction to opioids. Offering comprehensive services, combining the use of opioid agonist medications (buprenorphine/naloxone and naltrexone) with structured group and individual therapy.

Dialectical Behavior Therapy (DBT)

To treat adults with complex behavioral health conditions, including borderline personality disorder, suicide attempts and ideation, trauma and multiple mental health diagnoses. The 6-month, structured program includes weekly psychotherapy sessions and skills groups with specially trained clinicians who teach the core concepts of mindfulness, emotion regulation, distress tolerance and interpersonal effectiveness skills.

Mind/Body Wellness Clinic

A primary care clinic, integrated in the Outpatient Behavioral Health Center that provides compassionate, patient- and family-centered care that integrates primary care and behavioral healthcare to meet the complete needs of the patient.

Esketamine Clinic at Memorial

The first certified esketamine treatment center in South Florida to offer SPRAVATO™ for adults who have tried multiple oral antidepressants with little to no relief in their symptoms.

And coming soon, Transcranial Magnetic Stimulation (TMS) a noninvasive technological breakthrough that involves applying a series of short magnetic pulses to stimulate nerve cells in areas of the brain known to be associated with major depression. The electromagnet painlessly delivers a magnetic pulse that stimulates nerve cells in the region of your brain involved in mood control and depression. This new technology and treatment has been funded by generous donors through the Memorial Foundation.

About Memorial Outpatient Behavioral Health Center

For more than 30 years, Memorial Outpatient Behavioral Health Center has provided comprehensive adult mental health and addiction treatment—including psychiatry, behavioral health counseling, and primary care services—focused on helping patients develop health and wellness in all areas of their lives.

ClinOne Expands Patient Ride to Serve Global Clinical Trials


By reducing the barriers presented by transportation, we enable a more diverse population greater access to participating in life-changing research.

The ClinOne Patient Ride solution, in collaboration with Uber Health, currently enables clinical staff and patients to arrange transportation to a US clinic or lab, within the ClinOne platform.

Expanding the Patient Ride solution globally means enabling patient and provider relationships worldwide, providing more opportunities to gather and analyze high-fidelity data on an international scale, particularly with previously untapped patient populations. “Broadening ClinOne’s reach through our global partnership with Uber provides easy-to-access transportation services, vital for all patients with varying needs to have peace of mind for their successful participation in a clinical trial. Providing a turnkey way for sites to arrange for these services gives them one less thing to do and enables them to focus on patient care,” says Andrea Valente, CEO of ClinOne.

The ease-of-use, centralized billing and real-time confirmation of patient transportation has been a boon for US clinical sites to recruit formerly underserved populations. “Increasing diversity, inclusion, and equity in drug development cannot be an afterthought; it must be meticulously incorporated every step of the way,” Brian Ongioni, Vice President of Product at ClinOne notes. “By reducing the barriers presented by transportation, we enable a more diverse population greater access to participating in life-changing research.”

Decentralized Clinical Trial (DCT) design is an important part of the changing landscape for clinical trials, and transportation is a key driver for that change. In a survey sponsored by the Michael J. Fox Foundation cited in Applied Clinical Trials, “95% [of sites] reported that transportation infrastructure would improve recruitment efforts, and 63% felt it would ensure all studies recruited on time. Eighty-four percent of respondents reported that a taxi, livery, or ride-sharing service partnership would be the preferred transportation infrastructure.”

1,250+ Patient Rides Provided in a Single Study is only one example of how Patient Ride bolsters accessibility and flexibility and drives significant ROI by enrolling faster, improving experience, and increasing patient retention.

To learn more about ClinOne’s solutions or Adaptive Experiences, visit http://www.clinone.com.

Share article on social media or email:

NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral Palsy


NeuroCytonix Logo

NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral Palsy

NeuroCytonix, Inc. (the “Company” or “NeuroCytonix”) today announced that on January 19, 2023, its subsidiary NeuroCytonix Mexico has received a regulatory acknowledgment letter from the Mexican regulatory authority COFEPRIS – ref/memorandum number 223300ES450795/2023 – following the presentation of NeuroCytonix final report on its clinical trial on Cerebral Palsy NCX-CP-01.

COFEPRIS is member of the International Council of Harmonization (ICH) and Pharmaceutical Inspection Cooperation Scheme (PIC/S). In addition, COFEPRIS is a Level IV: National Regulatory Authority competent and efficient in the performance of the health regulatory functions recommended by PAHO / WHO.

The acknowledgment represents the legal and formal conclusion of the clinical trial, according to the methodology authorized by COFEPRIS. The resolution of the NCX-CP-01 clinical trial provides safety and efficacy data on investigational NeuroCytotron treatment of Cerebral Palsy. A manuscript detailing the results of this clinical trial is currently under preparation and will soon be submitted to several scientific journals.

The results of this clinical trial provide support for additional studies that will continue to evaluate the ongoing application of therapies with the NeuroCytotron in larger groups of patients, which will be supported by a Standard Operating Procedure where all cases will be recorded. This acknowledgment confirms that NeuroCytonix is ​​a company that has formally concluded a clinical trial for its investigational NeuroCytotron treatment and is now registered in the National Registry of Research Companies in Mexico.

About NeuroCytonix

NeuroCytonix is an emerging biotechnology business founded in January 2017 by Dr. J Roberto Trujillo to develop and exploit transformational medical technologies for the regeneration of the nervous system. The Company’s technology and related protocols include Stroke, Autism, Cerebral Palsy and neurological consequences of Traumatic Brain Injury (TBI) and Covid19. The Company’s core technology, the NEUROCYTOTRON, utilizes non-invasive, safe, tissue engineering technology that stimulates proteins which aid in the regeneration of brain cells.

The NeuroCytonix technology is based on the work of Dr. Rajah V Kumar, inventor of the Cytotron and a pioneer for more than 30 years in the field of biophysics, radiobiology, and regenerative tissue engineering.

The NeuroCytonix founder and CEO, Dr. J. Roberto Trujillo, an MD and PhD from Harvard University, is a leader in clinical and basic neuroscience research and molecular virology for brain diseases and is transforming the status quo of healthcare for these previously believed incurable conditions.

NeuroCytonix has built a Research Center in Monterrey Mexico where it has trained and directed a clinical research team who has successfully implemented its first Cerebral Palsy clinical trial evaluating the safety and efficacy of the treatment.

Link to the full study on ClinticalTrials.gov.

Please visit http://www.neurocytonix.com for more information.

Contact:

Laurent Lavigne du Cadet

Chief Financial Officer

llavigne@neurocytonix.com

Share article on social media or email:

Juno Diagnostics’ Co-Founder and CEO, Dirk van den Boom, Accepted into Forbes Business Council


News Image

As a co-founder and CEO, this gives me the opportunity to connect with others on their perspectives related to women’s healthcare, diagnostics, genetic testing solutions, and the overall landscape of the medical industry.

Juno Diagnostics™, Inc. (JunoDx™), a women’s health company focused on improving equitable access to prenatal care led by industry experts, announced today that its co-founder and CEO, Dirk van den Boom, has been accepted into the Forbes Business Council, an invitation-only community for successful business owners and leaders worldwide.

Dr. Van den Boom was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors.

“We are honored to welcome Dirk van den Boom into the community,” said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council. “Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world.”

As an accepted member of the Council, Dr. Van den Boom has access to a variety of exclusive opportunities designed to help him reach peak professional influence. He will connect and collaborate with other respected local leaders in a private forum and at members-only events. Van den Boom will also be invited to work with a professional editorial team to share his expert insights in original business articles on Forbes.com, and to contribute to published Q&A panels alongside other experts.

Finally, Dr. Van den Boom will benefit from exclusive access to vetted business service partners, membership-branded marketing collateral, and the high-touch support of the Forbes Councils’ member concierge team.

“I am thrilled to be asked to join the Forbes Business Council,” said Dr. Van den Boom. “As a co-founder and CEO, this gives me the opportunity to connect with others on their perspectives related to women’s healthcare, diagnostics, genetic testing solutions, and the overall landscape of the medical industry. Juno Diagnostics will only continue to grow these partnerships and secure our role as a leading women’s health company that provides equitable access to prenatal care.”

About Forbes Councils

Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded the Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive.

To learn more about Forbes Councils, visit forbescouncils.com.

About Juno Diagnostics™

Juno Diagnostics™ is a category-defining health company bringing vital prenatal health information to patients by combining accessibility, affordability, and transparency. The Company has developed a proprietary Sample Collection Kit and Device to facilitate capillary blood-based testing. Its lead product, the Juno Hazel™ test, is a non-invasive prenatal screening (NIPS) test that utilizes the proprietary Sample Collection Kit and improves access to high-quality testing results without the high cost, long lead times, and phlebotomy requirements of traditional NIPS.

For more information, visit http://www.junodx.com and engage with us on LinkedIn.

Share article on social media or email:

International Health Insurance for Digital Nomads


Genki, the health and insurtech startup focused on digital nomads, is proud to announce Genki World Resident, an innovative international health insurance plan designed specifically for long-term digital nomads and nomad families.

Genki World Resident is a comprehensive health insurance plan that covers the cost of medically necessary treatment and preventive care around the world. It is available to people of all ages and from any country, regardless of citizenship or residence.

“With Genki World Resident, digital nomads no longer have to choose between traveling the world and taking great care of their health.” said Neville A Mehra, Co-founder of Genki.

Genki World Resident includes health, vision, and dental coverage, as well as cover for prenatal care & childbirth, alternative treatments (such as homeopathy and osteopathy), chiropractic care, physiotherapy, and much more.

World Resident members can receive care at any locally-licensed healthcare provider in any country in the world, with no maximum benefit limit for medical treatment.

In addition, Genki World Resident comes with telemedicine access and a 24/7 emergency assistance hotline, who can arrange direct billing with any hospital.

For more information and early access visit: https://genki.world/insurance/world-resident

###

About Genki:

Genki is the startup focused on health for digital nomads. Genki’s mission is to help nomads be healthy and live well wherever they go. The German company has developed innovative international health insurance plans to support the growing community of digital nomads and nomad families. With Genki, digital nomads no longer have to choose between traveling the world and taking great care of their health.

Share article on social media or email:

Spaulding Academy & Family Services Adds Two to Leadership Team


Spaulding Academy & Family Services New Leadership Additions, Courtrney Constant and Nick Silva

Spaulding Academy & Family Services New Leadership Additions, Courtrney Constant and Nick Silva

“We are excited to welcome these young professionals to our leadership team and look forward to the contributions, passion and fresh perspectives these two individuals will undoubtedly bring to our experienced leadership team,’ said Todd Emmons, CEO, Spaulding Academy & Family Services.

Spaulding Academy & Family Services has named two new directors to their executive leadership team. Courtney Constant has joined as the organization’s Director of Development and Community Relations and Nick Silva was recently promoted to Director of Admissions.

Constant previously worked in real estate as Director of Operations at Lake Life Realty – Compass New England since 2018. In her role at Lake Life Realty, she led the agency’s team to raise over $200,000 for Make-A-Wish New Hampshire and continues to volunteer on the Rafting for Wishes event planning committee. Constant holds a master’s degree in Human Relations and a bachelor’s degree in Psychology from Plymouth State University.

Since joining Spaulding Academy & Family Services in 2014, Silva was successful in several roles across campus, including Academic Aide, Paraprofessional, Residential Counselor and Associate Teacher. This experience made him uniquely qualified to earn a promotion to Admissions Assistant in 2017. As the Admissions Assistant, he worked closely with each department on campus to lead tours, follow up on new student’s progress and be a part of the Spaulding enrollment process from start to finish. Silva holds an MBA from Southern New Hampshire University and a bachelor’s degree from Elms College.

“We are excited to welcome these young professionals to our leadership team and look forward to the contributions, passion and fresh perspectives these two individuals will undoubtedly bring to our experienced leadership team,” said Todd Emmons, Chief Executive Officer, Spaulding Academy & Family Services. “As an ever-evolving organization, Spaulding is continuously looking for opportunities to promote from within and demonstrate our campus-wide dedication to diversity.”

For more information regarding currently available positions, visit SpauldingServices.org/jobs.

ABOUT SPAULDING ACADEMY & FAMILY SERVICES

Spaulding Academy & Family Services is a leading provider of educational, residential, therapeutic and community-based programs and services for families, and children and youth with neurological, emotional, behavioral, learning or developmental challenges, including Autism Spectrum Disorder and those who have experienced significant trauma, abuse or neglect. Established in 1871 as the New Hampshire Orphans Home and School for Industry, Spaulding Academy & Family Services is the oldest child care organization in operation in the United States. It is a is a tax-exempt 501(c)(3) nonprofit that was formerly known as Spaulding Youth Center since 1958. Its scenic hilltop campus is located on over 500 acres in Northfield, NH and welcomes boys and girls from ages 4 to 22 from around the state of New Hampshire and beyond. In addition to programs provided on the Northfield campus, Spaulding’s community-based programs include foster family licensing, Individual Service Option (ISO) foster care, ISO in-home services, child health support services, and more for children ages 0 to 20 and their family. For information about Spaulding Academy & Family Services, visit http://www.SpauldingServices.org.

Share article on social media or email:

Dr. Cherag Daruwala of Hunterdon Gastroenterology Awarded As NJ Top Doc


Cherag Daruwala, MD

Cherag Daruwala, MD

Like many gastroenterologists, I enjoy the technological aspect of my specialty. However, I am also receptive to patients who prefer a more holistic approach to treatment.

NJ Top Docs has reviewed and approved Dr. Cherag Daruwala of Hunterdon Gastroenterology Associates for 2022. This is Dr. Daruwala’s seventh consecutive year being reviewed and approved by NJ Top Docs. Dr. Daruwala is a board certified Gastroenterologist and Hepatologist.

After completing his fellowship in Gastroenterology, Dr. Daruwala went on to complete training in endoscopic ultrasound and was on staff at Temple University Hospital for 3 years prior to joining Hunterdon Gastroenterology Associates in 2012. Dr. Daruwala established the endoscopic ultrasound program at Hunterdon Medical Center.

“Like many gastroenterologists, I enjoy the technological aspect of my specialty. However, I am also receptive to patients who prefer a more holistic approach to treatment,” says Dr. Daruwala.

Dr Daruwala is among the first gastroenterologists to offer Endoscopic Ultrasound in Central New Jersey. This procedure offers an accurate and less invasive method for the diagnosis and staging of various cancers. In addition to Endoscopic ultrasound, he has a keen interest in colon cancer screening as well as the management of acid reflux disease, hepatitis and irritable bowel syndrome. He has offices in Flemington and Somerville, New Jersey.

To learn more about Dr. Cherag Daruwala, please visit: https://njtopdocs.com/nj-doctors/daruwala/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment. For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Sidestepping “The Talk” – New study explores the motives and consequences of avoiding those awkward yet necessary conversations


Trying to avoid awkward conversations only hurts us in the long-run.

Sidestepping that awkward conversation with your friend, partner, family member, or boss won’t do you any good in the long-run.

When we try to avoid something, it will usually continue to rear its head until we are forced to face it.

Parents giving the “birds and the bees” talk. Romantic partners wanting to know where the relationship is going. Confronting a jerk at work or having to apologize for being the jerk. Life is filled with conversations most people don’t want to have, but avoidance has consequences. Based on a study by PsychTests.com, the short-term respite of dodging that awkward talk can lead to long-term social and psychological repercussions.

Analyzing data collected from 12,259 people who took the Emotional Intelligence Test, PsychTests’ researchers compared the personality profile of two distinct groups: people who tend to avoid awkward conversations (“Avoiders”) and those who don’t (“Non-Avoiders”). Here’s what the results revealed:

AVOIDERS DON’T JUST DODGE AWKWARD CONVERSATIONS – THEY HAVE A TENDENCY TO EVADE ANYTHING THEY FIND UNPLEASANT.

> 52% of Avoiders are uncomfortable showing their emotions (vs. 21% of Non-Avoiders).

> 62% don’t like talking about their feelings (vs. 15% of Non-Avoiders).

> 53% feel awkward expressing affection or appreciation (vs. 11% of Non-Avoiders).

> 56% will actually suppress their own negative emotions rather than face them (vs. 32% of Non-Avoiders).

> 69% dodge confrontation (vs. 18% of Non-Avoiders).

> 77% won’t ask for what they want – a raise in salary, for example – even when they really desire it or feel they deserve it (vs. 20% of Non-Avoiders).

> 55% are too self-conscious to ask questions if they don’t understand something (vs. 10% of Non-Avoiders).

> 59% get tongue-tied talking to authority figures (vs. 12% of Non-Avoiders).

> 43% won’t correct their teacher or boss when he/she makes a mistake (vs. 25% of Non-Avoiders).

> 41% refrain from giving people advice for fear of steering them in the wrong direction (vs. 10% of Non-Avoiders).

According to PsychTests researchers, their study pointed to some potential motives for Avoiders’ tendency to sidestep awkward conversations, among other things they find disagreeable:

> 76% of Avoiders lack the willpower to push themselves to do things they don’t like (vs. 24% of Non-Avoiders).

> 75% feel like a “fish out of water” in most social situations (vs. 31% of Non-Avoiders).

> 46% are intimidated by anyone with a strong personality (vs. 11% of Non-Avoiders).

> 49% said that they have no idea how to deal with someone who is upset (vs. 9% of Non-Avoiders).

> 57% will hold back from expressing their ideas or opinions if there is a chance they may be mocked or ridiculed (vs. 11% of Non-Avoiders).

> 62% have a desperate need to be liked by everyone (vs. 30% of Non-Avoiders).

POTENTIAL CONSEQUENCES OF AVOIDANCE, ACCORDING TO PSYCHTESTS’ STUDY:

> 50% of Avoiders experience frequent emotional ups and downs (vs. 19% of Non-Avoiders).

> 60% frequently put other people’s needs ahead of their own, even when it leaves them feeling sad, upset, or resentful (vs. 37% of Non-Avoiders).

> 52% will pretend to agree with someone’s opinion in order to avoid a fight (vs. 16% of Non-Avoiders).

> 57% will spend hours analyzing and dissecting a person’s comments rather than just asking what he/she meant, or confronting someone who has hurt their feelings (vs. 21% of Non-Avoiders).

> 57% will apologize even when they know they haven’t done anything wrong (vs. 32% of Non-Avoiders).

> 33% of Avoiders are currently undergoing therapy for depression or suspect that they might be depressed (vs. 13% of Non-Avoiders).

> 33% of Avoiders are currently undergoing therapy for an anxiety disorder or suspect that they might have anxiety issues (vs. 18% of Non-Avoiders).

“You can probably avoid some unpleasant conversations but you can’t run from them forever. When we try to avoid something, it will usually continue to rear its head until we are forced to face it,” explains Dr. Ilona Jerabek, president of PsychTests. “People often try to avoid awkward conversations for fear of embarrassment or emotional pain. For example, we might decide not to bring up a problem, no matter how miserable it makes us, because we’re afraid that it could result in a relationship-ending fight or getting fired at work. In fact, 14% of the Avoiders in our study said that they’d rather walk away from a fight or let the other person win, compared to 6% of Non-Avoiders. The reality is that very often, those unpleasant conversations are necessary, and in the long-run, it will be far more difficult to live with a problem than to face it and talk about it. As we have seen in our study, avoidance leaves people feeling unhappy and unfulfilled.”

“For those who tend to sidestep sensitive conversations, my advice would be to face the unpleasantness head-on. Write down exactly what you want to say, and if possible, bring someone for emotional support. Practice saying it to get more comfortable with the message. Learn about assertiveness techniques, and ideally find a coach who can help you practice. Keep in mind that even the most difficult discussions can happen calmly and with a positive tone if you can deliver the message assertively, but with empathy . Most importantly, think about all the consequences of not speaking up. If they outweigh the repercussions of avoidance, then take it as a sign that this is a conversation you need to have.”

What’s your EQ? Check out the Emotional Intelligence Test at https://testyourself.psychtests.com/testid/3979

Professional users, such as HR managers, coaches, and therapists, can request a free demo for this or other assessments from ARCH Profile’s extensive battery: http://hrtests.archprofile.com/testdrive_gen_1

To learn more about psychological testing, download this free eBook: http://hrtests.archprofile.com/personality-tests-in-hr

About PsychTests AIM Inc.

PsychTests AIM Inc. originally appeared on the internet scene in 1996. Since its inception, it has become a pre-eminent provider of psychological assessment products and services to human resource personnel, therapists and coaches, academics, researchers and a host of other professionals around the world. PsychTests AIM Inc. staff is comprised of a dedicated team of psychologists, test developers, researchers, statisticians, writers, and artificial intelligence experts (see ARCHProfile.com).

Share article on social media or email:

NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral Palsy


NeuroCytonix Logo

NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral Palsy

NeuroCytonix, Inc. (the “Company” or “NeuroCytonix”) today announced that on January 19, 2023, its subsidiary NeuroCytonix Mexico has received a regulatory acknowledgment letter from the Mexican regulatory authority COFEPRIS – ref/memorandum number 223300ES450795/2023 – following the presentation of NeuroCytonix final report on its clinical trial on Cerebral Palsy NCX-CP-01.

The acknowledgment represents the legal and formal conclusion of the clinical trial, according to the methodology authorized by COFEPRIS. The resolution of the NCX-CP-01 clinical trial provides safety and efficacy data on investigational NeuroCytotron treatment of Cerebral Palsy. A manuscript detailing the results of this clinical trial is currently under preparation and will soon be submitted to several scientific journals.

The results of this clinical trial provide support for additional studies that will continue to evaluate the ongoing application of therapies with the NeuroCytotron in larger groups of patients, which will be supported by a Standard Operating Procedure where all cases will be recorded. This acknowledgment confirms that NeuroCytonix is ​​a company that has formally concluded a clinical trial for its investigational NeuroCytotron treatment and is now registered in the National Registry of Research Companies in Mexico.

About NeuroCytonix

NeuroCytonix is an emerging biotechnology business founded in January 2017 to develop and exploit transformational medical technologies for the regeneration of the nervous system. The Company’s technology and related protocols include Stroke, Autism, Cerebral Palsy and neurological consequences of Traumatic Brain Injury (TBI) and Covid19. The Company’s core technology, the NEUROCYTOTRON, utilizes non-invasive, safe, tissue engineering technology that stimulates proteins which aid in the regeneration of brain cells.

The NeuroCytonix technology is based on the work of its founder and CEO, Dr. J. Roberto Trujillo, an MD and PhD from Harvard University who has been a leader in clinical and basic neuroscience research for brain regeneration technology for the past 25 years. Dr. Trujillo has devoted his career to pioneering regenerative medicine technologies with the hope of transforming the status quo of healthcare for these previously believed incurable conditions.

NeuroCytonix has built a Research Center in Monterrey Mexico where it has trained and directed a clinical research team who has successfully implemented its first Cerebral Palsy clinical trial evaluating the safety and efficacy of the treatment.

Link to the full study on ClinticalTrials.gov.

Please visit http://www.neurocytonix.com for more information.

Contact:

Laurent Lavigne du Cadet

Chief Financial Officer

llavigne@neurocytonix.com

Share article on social media or email: